関連ニュース

Amgen NASDAQ: AMGN executives highlighted growth across its key commercial products, progress in late-stage development programs and a continued focus on profitability and cash returns during a Wells

Amgen TodayAMGNAmgen$379.72 -2.75 (-0.72%) As of 12:05 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$269.77▼$447.03Dividend Yield2.65%P/E Ratio23.61Price T

Novartis' pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly.

Representative David J. Taylor, a Republican from Ohio, has reported six congressional stock trades, selling off holdings in biotech and technology while purchasing shares in utility, semiconductor, a

Repatha is the First and Only PCSK9 Inhibitor Shown to Lower the Risk of Dying from All Causes, Including Cardiovascular Events, in High-Risk Primary Prevention Patients in a Phase 3 Trial Separate Gl

Moderna, Revolution Medicines, and Amgen are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that develop

Amgen Inc. (AMGN) Q2 2026 Earnings Call Transcript

Markets face a pivotal week as jobs data, Fed speakers and earnings from SpaceX, AMD and Palantir test sentiment and the AI outlook.